Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-AnalysisJoseph Jankovic, Jie Shen, Terry Boodhoo et al.|Toxins|2023Cited by 39
Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention studyRobyn H. Guymer, Glenn J. Jaffe, Philip J. Rosenfeld et al.|Experimental Eye Research|2025Cited by 5